BLRX - バイオラインRx (BioLineRx Ltd.) バイオラインRx

 BLRXのチャート


 BLRXの企業情報

symbol BLRx
会社名 BioLineRx Ltd (バイオラインRx)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種    医療関連(Health Care)
概要 事業概要 --   バイオラインRXはイスラエルのバイオ医薬品メ―カ―。中枢神経系疾患、感染性疾患、心臓血管疾患、自己免疫疾患などの治療法の開発に焦点を置く。急性心筋梗塞、急性骨髄性白血病、セリアック病、良性皮膚腫瘍、炎症性腸疾患、C型肝炎ウイルスなどの臨床段階治療薬候補を保有する。   
本社所在地 2 HaMa'ayan Street Modi'in 7177871 ISR
代表者氏名
代表者役職名
電話番号
設立年月日 37712
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 48人
url www.biolinerx.com
nasdaq_url https://www.nasdaq.com/symbol/blrx
adr_tso 83425172
EBITDA EBITDA ー
終値(lastsale) 1.27
時価総額(marketcap) 105949968.44
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 BLRXのテクニカル分析


 BLRXのニュース

   BioLineRx Increases Previously Announced Bought Deal Offering to $30 Million - Stocks News Feed  2021/01/20 02:42:00 Stocks News Feed
TEL AVIV, Israel, Jan. 20, 2021 /PRNewswire/ — BioLineRx Ltd. (NASDAQ:BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, today announced that due to demand, the underwriter has agreed to increase the size of the previously announced offering and purchase on a firm commitment basis 12,500,000 American Depositary Shares (ADSs) of the Company,… Read More »BioLineRx Increases Previously Announced Bought Deal Offering to $30 Million
   BioLineRx Announces Final Results from Phase 2a COMBAT/KEYNOTE-202 Triple Combination Study of Motixafortide in Second Line Metastatic Pancreatic Cancer (PDAC)  2020/12/16 11:01:00 PR Newswire
/PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical Company focused on oncology, today announced results from…
   A Case Study Why It's Worthwhile Joining Wheel Of Fortune & Following Us On Twitter - The Fortune Teller  2020/12/14 21:43:00 Seeking Alpha
Here's a tale about a stock name BiolineRX (BLRX), a micro-cap biotech, that we cover on both Wheel of Fortune as well on Twitter.
   BioLineRx Reports Third Quarter 2020 Financial Results and Provides Corporate Update  2020/11/23 12:00:00 PR Newswire
/PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, today reports its financial…
   BioLineRx to Report Third Quarter 2020 Results on November 23, 2020  2020/11/18 12:00:00 PR Newswire
/PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, announced today it will…
   BioLineRx Announces Final Results from Phase 2a COMBAT/KEYNOTE-202 Triple Combination Study of Motixafortide in Second Line Metastatic Pancreatic Cancer (PDAC)  2020/12/16 11:01:00 PR Newswire
/PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical Company focused on oncology, today announced results from…
   A Case Study Why It's Worthwhile Joining Wheel Of Fortune & Following Us On Twitter - The Fortune Teller  2020/12/14 21:43:00 Seeking Alpha
Here's a tale about a stock name BiolineRX (BLRX), a micro-cap biotech, that we cover on both Wheel of Fortune as well on Twitter.
   BioLineRx Reports Third Quarter 2020 Financial Results and Provides Corporate Update  2020/11/23 12:00:00 PR Newswire
/PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, today reports its financial…
   BioLineRx to Report Third Quarter 2020 Results on November 23, 2020  2020/11/18 12:00:00 PR Newswire
/PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, announced today it will…
   BiolineRX soars on positive Phase 3 blood cancer trial results  2020/11/01 15:14:59 Globes English
The company has reported positive results from an ongoing trial for stem cell mobilization in multiple myeloma (blood cancer) patients.
   A Case Study Why It's Worthwhile Joining Wheel Of Fortune & Following Us On Twitter - The Fortune Teller  2020/12/14 21:43:00 Seeking Alpha
Here's a tale about a stock name BiolineRX (BLRX), a micro-cap biotech, that we cover on both Wheel of Fortune as well on Twitter.
   BioLineRx Reports Third Quarter 2020 Financial Results and Provides Corporate Update  2020/11/23 12:00:00 PR Newswire
/PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, today reports its financial…
   BioLineRx to Report Third Quarter 2020 Results on November 23, 2020  2020/11/18 12:00:00 PR Newswire
/PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, announced today it will…
   BiolineRX soars on positive Phase 3 blood cancer trial results  2020/11/01 15:14:59 Globes English
The company has reported positive results from an ongoing trial for stem cell mobilization in multiple myeloma (blood cancer) patients.
   BioLineRX News: Why BLRX Stock Is Skyrocketing Today  2020/10/30 15:13:42 InvestorPlace
BLRX stock is blasting off on Friday morning after the company reported strong results from a Phase-3 trial for one of its cancer treatments.

 関連キーワード  (― 米国株 バイオラインRx BLRX BioLineRx Ltd.)

 twitter  (公式ツイッターやCEOツイッターなど)